Genetic association studies of suicidal behavior: A review of the past 10 years, progress, limitations, and future directions

Frontiers in Psychiatry

Volumn 7, Issue SEP, 2016, Pages

  Mirkovic, Bojan ^a,b,c   Laurent, Claudine ^c,d   Podlipski, Marc Antoine ^a   Frebourg, Thierry ^a,b   Cohen, David ^c,e   Gerardin, Priscille ^a,f  

^a HÔPITAL CHARLES NICOLLE   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^e UNIVERSITÉ PIERRE ET MARIE CURIE   (France)

^f UNIVERSITÉ DE ROUEN   (France)

Author keywords

Association study; Genetics of suicide; Single nucleotide polymorphism; Suicidal behavior

Indexed keywords

ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE RECEPTOR; ORNITHINE DECARBOXYLASE; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; TRYPTOPHAN HYDROXYLASE 2; UNCLASSIFIED DRUG;

ADOLESCENT DISEASE; ADRA2A GENE; BDNF GENE; COMT GENE; DRD2 GENE; GENE; GENE CANDIDATE ASSOCIATION STUDY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC ASSOCIATION STUDY; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE ENVIRONMENT INTERACTION; GRIA3 GENE; GRIK2 GENE; GRIN2B GENE; HTR1A GENE; HTR1B GENE; HUMAN; HUMAN GENOME; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAOA GENE; NTKR2 GENE; NTRK2 GENE; ODC1 GENE; REVIEW; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SLC6A4 GENE; SUICIDAL BEHAVIOR; TPH1 GENE; TPH2 GENE;

EID: 84991744583     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2016.00158     Document Type: Review

References (171)

1. World Health Organization (WHO). Public Health Action for the Prevention of Suicide: A Framework. Geneva: WHO (2012).
2. Organisation for Economic Cooperation and Development (OECD). Health at a Glance. Europe 2012. Paris: OECD Publishing (2012). 154 p.
3. Mann JJ, Arango VA, Avenevoli S, Brent DA, Champagne FA, Clayton P, et al. Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry (2009) 65:556-63. doi:10.1016/j.biopsych.2008.11.021
4. Hawton K, van Heeringen K. Suicide. Lancet (2009) 373:1372-81. doi:10.1016/S0140-6736(09)60372-X
5. Brent DA, Bridge J, Johnson BA, Connolly J. Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch Gen Psychiatry (1996) 53:1145-52. doi:10.1001/archpsyc.1996.01830120085015
6. Roy A, Segal NL, Centerwall BS, Robinette CD. Suicide in twins. Arch Gen Psychiatry (1991) 48:29-32. doi:10.1001/archpsyc.1991.01810250031003
7. Baldessarini RJ, Hennen J. Genetics of suicide: an overview. Harv Rev Psychiatry (2004) 12:1-13. doi:10.1080/714858479
8. Cho H, Guo G, Iritani BJ, Hallfors DD. Genetic contribution to suicidal behaviors and associated risk factors among adolescents in the U.S. Prev Sci (2006) 7:303-11. doi:10.1007/s11121-006-0042-5
9. Pedersen NL, Fiske A. Genetic influences on suicide and nonfatal suicidal behavior: twin study findings. Eur Psychiatry (2010) 25:264-7. doi:10.1016/j.eurpsy.2009.12.008
10. Brent DA, Mann JJ. Family genetic studies, suicide, and suicidal behavior. Am J Med Genet C Semin Med Genet (2005) 133C:13-24. doi:10.1002/ajmg.c.30042
11. Althoff RR, Hudziak JJ, Willemsen G, Hudziak V, Bartels M, Boomsma DI. Genetic and environmental contributions to self-reported thoughts of self-harm and suicide. Am J Med Genet B Neuropsychiatr Genet (2012) 159B:120-7. doi:10.1002/ajmg.b.32010
12. Roy A, Segal NL. Suicidal behavior in twins: a replication. J Affect Disord (2001) 66:71-4. doi:10.1016/S0165-0327(00)00275-5
13. McGirr A, Diaconu G, Berlim MT, Pruessner JC, Sablé R, Cabot S, et al. Dysregulation of the sympathetic nervous system, hypothalamic-pituitary-adrenal axis and executive function in individuals at risk for suicide. J Psychiatry Neurosci (2010) 35:399-408. doi:10.1503/jpn.090121
14. Brent DA, Perper JA, Moritz G, Allman C, Friend A, Roth C, et al. Psychiatric risk factors for adolescent suicide: a case-control study. J Am Acad Child Adolesc Psychiatry (1993) 32:521-9. doi:10.1097/00004583-199305000-00006
15. Brent D, Melhem N, Ferrell R, Emslie G, Wagner KD, Ryan N, et al. Association of FKBP5 polymorphisms with suicidal events in the treatment of resistant depression in adolescents (TORDIA) study. Am J Psychiatry (2010) 167:190-7. doi:10.1176/appi.ajp.2009.09040576
16. Henriksson MM, Aro HM, Marttunen MJ, Heikkinen ME, Isometsä ET, Kuoppasalmi KI, et al. Mental disorders and comorbidity in suicide. Am J Psychiatry (1993) 150(6):935-40. doi:10.1176/ajp.150.6.935
17. Turecki G, Brent DA. Suicide and suicidal behaviour. Lancet (2016) 387(10024):1227-39. doi:10.1016/S0140-6736(15)00234-2
18. Turecki G. Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J Psychiatry Neurosci (2005) 30:398-408.
19. Brezo J, Bureau A, Mérette C, Jomphe V, Barker ED, Vitaro F, et al. Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study. Mol Psychiatry (2010) 15:831-43. doi:10.1038/mp.2009.19
20. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 301:386-9. doi:10.1126/science.1083968
21. Kendler KS. Genetic and environmental pathways to suicidal behavior: reflections of a genetic epidemiologist. Eur Psychiatry (2010) 25:300-3. doi:10.1016/j.eurpsy.2010.01.005
22. International HapMap Consortium. A haplotype map of the human genome. Nature (2005) 437:1299-320. doi:10.1038/nature04226
23. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet (2005) 37:1217-23. doi:10.1038/ng1669
24. Matsuzaki H, Dong S, Loi H, Di X, Liu G, Hubbell E, et al. Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods (2004) 1:109-11. doi:10.1038/nmeth718
25. Bunney WE, Bunney BG, Vawter MP, Tomita H, Li J, Evans SJ, et al. Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am J Psychiatry (2003) 160:657-66. doi:10.1176/appi.ajp.160.4.657
26. Kennedy GC, Matsuzaki H, Dong S, Liu WM, Huang J, Liu G, et al. Large-scale genotyping of complex DNA. Nat Biotechnol (2003) 21:1233-7. doi:10.1038/nbt869
27. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 6:e1000097. doi:10.1371/journal.pmed.1000097
28. Asberg M. Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann N Y Acad Sci (1997) 836:158-81. doi:10.1111/j.1749-6632.1997.tb52359.x
29. Mann JJ, Brent DA, Arango V. The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology (2001) 24:467-77. doi:10.1016/S0893-133X(00)00228-1
30. Mann JJ. The serotonergic system in mood disorders and suicidal behaviour. Philos Trans R Soc Lond B Biol Sci (2013) 368:20120537. doi:10.1098/rstb.2012.0537
31. Anguelova M, Benkelfat C, Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol Psychiatry (2003) 8:646-53. doi:10.1038/sj.mp.4001336
32. Brezo J, Klempan T, Turecki G. The genetics of suicide: a critical review of molecular studies. Psychiatr Clin North Am (2008) 31:179-203. doi:10.1016/j.psc.2008.01.008
33. Antypa N, Serretti A, Rujescu D. Serotonergic genes and suicide: a systematic review. Eur Neuropsychopharmacol (2013) 23:1125-42. doi:10.1016/j.euroneuro.2013.03.013
34. Zalsman G, Frisch A, King RA, Pauls DL, Grice DE, Gelernter J, et al. Case control and family-based studies of tryptophan hydroxylase gene A218C polymorphism and suicidality in adolescents. Am J Med Genet (2001) 105(5):451-7. doi:10.1002/ajmg.1406
35. Courtet P, Jollant F, Castelnau D, Astruc B, Buresi C, Malafosse A. [Implication of genes of the serotonergic system on vulnerability to suicidal behavior]. J Psychiatry Neurosci (2004) 29:350-9.
36. Ohtani M, Shindo S, Yoshioka N. Polymorphisms of the tryptophan hydroxylase gene and serotonin 1A receptor gene in suicide victims among Japanese. Tohoku J Exp Med (2004) 202:123-33. doi:10.1620/tjem.202.123
37. Stefulj J, Kubat M, Balija M, Skavic J, Jernej B. Variability of the tryptophan hydroxylase gene: study in victims of violent suicide. Psychiatry Res (2005) 134:67-73. doi:10.1016/j.psychres.2004.04.011
38. Liu X, Li H, Qin W, He G, Li D, Shen Y, et al. Association of TPH1 with suicidal behaviour and psychiatric disorders in the Chinese population. J Med Genet (2006) 43:e4. doi:10.1136/jmg.2004.029397
39. Stefulj J, Kubat M, Balija M, Jernej B. TPH gene polymorphism and aging: indication of combined effect on the predisposition to violent suicide. Am J Med Genet B Neuropsychiatr Genet (2006) 141B:139-41. doi:10.1002/ajmg.b.30271
40. Viana MM, De Marco LA, Boson WL, Romano-Silva MA, Corrêa H. Investigation of A218C tryptophan hydroxylase polymorphism: association with familial suicide behavior and proband's suicide attempt characteristics. Genes Brain Behav (2006) 5(4):340-5. doi:10.1111/j.1601-183X.2005.00171.x
41. Galfalvy H, Huang YY, Oquendo MA, Currier D, Mann JJ. Increased risk of suicide attempt in mood disorders and TPH1 genotype. J Affect Disord (2009) 115:331-8. doi:10.1016/j.jad.2008.09.019
42. Buttenschøn HN, Flint TJ, Foldager L, Qin P, Christoffersen S, Hansen NF, et al. An association study of suicide and candidate genes in the serotonergic system. J Affect Disord (2013) 148:291-8. doi:10.1016/j.jad.2012.12.011
43. Bellivier F, Chaste P, Malafosse A. Association between the TPH gene A218C polymorphism and suicidal behavior: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet (2004) 124B:87-91. doi:10.1002/ajmg.b.20015
44. Li D, He L. Further clarification of the contribution of the tryptophan hydroxylase (TPH) gene to suicidal behavior using systematic allelic and genotypic meta-analyses. Hum Genet (2006) 119:233-40. doi:10.1007/s00439-005-0113-x
45. Saetre P, Lundmark P, Wang A, Hansen T, Rasmussen HB, Djurovic S, et al. The tryptophan hydroxylase 1 (TPH1) gene, schizophrenia susceptibility, and suicidal behavior: a multi-centre case-control study and meta-analysis. Am J Med Genet B Neuropsychiatr Genet (2010) 153B:387-96. doi:10.1002/ajmg.b.30991
46. Clayden RC, Zaruk A, Meyre D, Thabane L, Samaan Z. The association of attempted suicide with genetic variants in the SLC6A4 and TPH genes depends on the definition of suicidal behavior: a systematic review and meta-analysis. Transl Psychiatry (2012) 2:e166. doi:10.1038/tp.2012.96
47. Zill P, Büttner A, Eisenmenger W, Möller HJ, Bondy B, Ackenheil M. Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol Psychiatry (2004) 56:581-6. doi:10.1016/j.biopsych.2004.07.015
48. Zhou Z, Roy A, Lipsky R, Kuchipudi K, Zhu G, Taubman J, et al. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Arch Gen Psychiatry (2005) 62:1109-18. doi:10.1001/archpsyc.62.10.1109
49. Ke L, Qi ZY, Ping Y, Ren CY. Effect of SNP at position 40237 in exon 7 of the TPH2 gene on susceptibility to suicide. Brain Res (2006) 1122:24-6. doi:10.1016/j.brainres.2006.09.007
50. Lopez de Lara C, Brezo J, Rouleau G, Lesage A, Dumont M, Alda M, et al. Effect of tryptophan hydroxylase-2 gene variants on suicide risk in major depression. Biol Psychiatry (2007) 62:72-80. doi:10.1016/j.biopsych.2006.09.008
51. Must A, Tasa G, Lang A, Vasar E, Koks S, Maron E, et al. Variation in tryptophan hydroxylase-2 gene is not associated to male completed suicide in Estonian population. Neurosci Lett (2009) 453(2):112-4. doi:10.1016/j.neulet.2009.02.010
52. Mouri K, Hishimoto A, Fukutake M, Shiroiwa K, Asano M, Nagasaki Y, et al. TPH2 is not a susceptibility gene for suicide in Japanese population. Prog Neuropsychopharmacol Biol Psychiatry (2009) 33(8):1546-50. doi:10.1016/j.pnpbp.2009.09.002
53. Fudalej S, Ilgen M, Fudalej M, Kostrzewa G, Barry K, Wojnar M, et al. Association between tryptophan hydroxylase 2 gene polymorphism and completed suicide. Suicide Life Threat Behav (2010) 40:553-60. doi:10.1521/suli.2010.40.6.553
54. Zhang Y, Zhang C, Yuan G, Yao J, Cheng Z, Liu C, et al. Effect of tryptophan hydroxylase-2 rs7305115 SNP on suicide attempts risk in major depression. Behav Brain Funct (2010) 6:49. doi:10.1186/1744-9081-6-49
55. Zupanc T, Pregelj P, Tomori M, Komel R, Paska AV. TPH2 polymorphisms and alcohol-related suicide. Neurosci Lett (2011) 490(1):78-81. doi:10.1016/j.neulet.2010.12.030
56. Stefulj J, Mokrovic G, Hranilovic D, Bordukalo-Niksic T, Bakula M, Kubat M, et al. Functional promoter polymorphism of the neuronal isoform of tryptophan hydroxylase (Tph2) in suicide. Psychiatry Res (2011) 186(2-3):446-7. doi:10.1016/j.psychres.2010.08.034
57. Musil R, Zill P, Seemüller F, Bondy B, Meyer S, Spellmann I, et al. Genetics of emergent suicidality during antidepressive treatment-data from a naturalistic study on a large sample of inpatients with a major depressive episode. Eur Neuropsychopharmacol (2013) 23:663-74. doi:10.1016/j.euroneuro.2012.08.009
58. González-Castro TB, Juárez-Rojop I, López-Narváez ML, Tovilla-Zárate CA. Association of TPH-1 and TPH-2 gene polymorphisms with suicidal behavior: a systematic review and meta-analysis. BMC Psychiatry (2014) 14:196. doi:10.1186/1471-244X-14-196
59. Wasserman D, Geijer T, Sokolowski M, Rozanov V, Wasserman J. The serotonin 1A receptor C(-1019)G polymorphism in relation to suicide attempt. Behav Brain Funct (2006) 2:14-9. doi:10.1186/1744-9081-2-14
60. Videtic A, Zupanc T, Pregelj P, Balazic J, Tomori M, Komel R. Suicide, stress and serotonin receptor 1A promoter polymorphism-1019C>G in Slovenian suicide victims. Eur Arch Psychiatry Clin Neurosci (2009) 259(4):234-8. doi:10.1007/s00406-008-0861-4
61. Wrzosek M, Lukaszkiewicz J, Wrzosek M, Serafin P, Jakubczyk A, Klimkiewicz A, et al. Association of polymorphisms in HTR2A, HTR1A and TPH2 genes with suicide attempts in alcohol dependence: a preliminary report. Psychiatry Res (2011) 190:149-51. doi:10.1016/j.psychres.2011.04.027
62. Samadi Rad B, Ghasemi A, Seifi M, Samadikuchaksaraei A, Baybordi F, Danaei N. Serotonin 1A receptor genetic variations, suicide, and life events in the Iranian population. Psychiatry Clin Neurosci (2012) 66:337-43. doi:10.1111/j.1440-1819.2012.02333.x
63. Höfer P, Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, et al. The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment-a European Multicentre Study. Int Clin Psychopharmacol (2016) 31:1-7. doi:10.1097/YIC.0000000000000101
64. Angles MR, Ocaña DB, Medellín BC, Tovilla-Zárate C. No association between the HTR1A gene and suicidal behavior: a meta-analysis. Rev Bras Psiquiatr (2012) 34:38-42. doi:10.1016/S1516-4446(12)70008-9
65. Murphy TM, Ryan M, Foster T, Kelly C, McClelland R, O'Grady J, et al. Risk and protective genetic variants in suicidal behaviour: association with SLC1A2, SLC1A3, 5-HTR1B &NTRK2 polymorphisms. Behav Brain Funct (2011) 7:22. doi:10.1186/1744-9081-7-22
66. Zouk H, McGirr A, Lebel V, Benkelfat C, Rouleau G, Turecki G. The effect of genetic variation of the serotonin 1B receptor gene on impulsive aggressive behavior and suicide. Am J Med Genet B Neuropsychiatr Genet (2007) 144B(8):996-1002. doi:10.1002/ajmg.b.30521
67. Kia-Keating BM, Glatt SJ, Tsuang MT. Meta-analyses suggest association between COMT, but not HTR1B, alleles, and suicidal behavior. Am J Med Genet B Neuropsychiatr Genet (2007) 144B:1048-53. doi:10.1002/ajmg.b.30551
68. Zalsman G, Frisch A, Baruch-Movshovits R, Sher L, Michaelovsky E, King RA, et al. Family-based association study of 5-HT(2A) receptor T102C polymorphism and suicidal behavior in Ashkenazi inpatient adolescents. Int J Adolesc Med Health (2005) 17(3):231-8. doi:10.1515/IJAMH.2005.17.3.231
69. Giegling I, Hartmann AM, Möller HJ, Rujescu D. Anger-and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene. J Affect Disord (2006) 96(1-2):75-81. doi:10.1016/j.jad.2006.05.016
70. Fanous AH, Chen X, Wang X, Amdur R, O'Neill FA, Walsh D, et al. Genetic variation in the serotonin 2A receptor and suicidal ideation in a sample of 270 Irish high-density schizophrenia families. Am J Med Genet B Neuropsychiatr Genet (2009) 150B:411-7. doi:10.1002/ajmg.b.30833
71. Yoon HK, Kim YK. TPH2-703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry (2009) 33:403-9. doi:10.1016/j.pnpbp.2008.12.013
72. Zalsman G, Patya M, Frisch A, Ofek H, Schapir L, Blum I, et al. Association of polymorphisms of the serotonergic pathways with clinical traits of impulsive-aggression and suicidality in adolescents: a multi-center study. World J Biol Psychiatry (2011) 12:33-41. doi:10.3109/15622975.2010.518628
73. Saiz PA, García-Portilla P, Paredes B, Corcoran P, Arango C, Morales B, et al. Role of serotonergic-related systems in suicidal behavior: data from a case-control association study. Prog Neuropsychopharmacol Biol Psychiatry (2011) 35:1518-24. doi:10.1016/j.pnpbp.2011.04.011
74. Ben-Efraim YJ, Wasserman D, Wasserman J, Sokolowski M. Family-based study of HTR2A in suicide attempts: observed gene, gene × environment and parent-of-origin associations. Mol Psychiatry (2013) 18(7):758-66. doi:10.1038/mp.2012.86
75. Li D, Duan Y, He L. Association study of serotonin 2A receptor (5-HT2A) gene with schizophrenia and suicidal behavior using systematic meta-analysis. Biochem Biophys Res Commun (2006) 340(3):1006-15. doi:10.1016/j.bbrc.2005.12.101
76. De Luca V, Tharmalingam S, King N, Strauss J, Bulgin N, Kennedy JL. Association study of a novel functional polymorphism of the serotonin transporter gene in bipolar disorder and suicidal behaviour. Psychopharmacology (Berl) (2005) 1:128-31. doi:10.1007/s00213-005-0046-z
77. Segal J, Pujol C, Birck A, Gus Manfro G, Leistner-Segal S. Association between suicide attempts in south Brazilian depressed patients with the serotonin transporter polymorphism. Psychiatry Res (2006) 143:289-91. doi:10.1016/j.psychres.2005.03.008
78. Wasserman D, Geijer T, Sokolowski M, Frisch A, Michaelovsky E, Weizman A, et al. Association of the serotonin transporter promotor polymorphism with suicide attempters with a high medical damage. Eur Neuropsychopharmacol (2007) 17:230-3. doi:10.1016/j.euroneuro.2006.08.006
79. Segal J, Schenkel LC, Oliveira MH, Salum GA, Bau CH, Manfro GG, et al. Novel allelic variants in the human serotonin transporter gene linked polymorphism (5-HTTLPR) among depressed patients with suicide attempt. Neurosci Lett (2009) 451(1):79-82. doi:10.1016/j.neulet.2008.12.015
80. Coventry WL, James MR, Eaves LJ, Gordon SD, Gillespie NA, Ryan L, et al. Do 5HTTLPR and stress interact in risk for depression and suicidality? Item response analyses of a large sample. Am J Med Genet B Neuropsychiatr Genet (2010) 153B:757-65. doi:10.1002/ajmg.b.31044
81. Neves FS, Malloy-Diniz LF, Romano-Silva MA, Aguiar GC, de Matos LO, Correa H. Is the serotonin transporter polymorphism (5-HTTLPR) a potential marker for suicidal behavior in bipolar disorder patients? J Affect Disord (2010) 125:98-102. doi:10.1016/j.jad.2009.12.026
82. Hung CF, Lung FW, Chen CH, O'Nions E, Hung TH, Chong MY, et al. Association between suicide attempt and a tri-allelic functional polymorphism in serotonin transporter gene promoter in Chinese patients with schizophrenia. Neurosci Lett (2011) 504:242-6. doi:10.1016/j.neulet.2011.09.036
83. Lin PY, Tsai G. Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis. Biol Psychiatry (2004) 55:1023-30. doi:10.1016/j.biopsych.2004.02.006
84. Li D, He L. Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Mol Psychiatry (2007) 12:47-54. doi:10.1038/sj.mp.4001890
85. Mann JJ, Malone KM, Nielsen DA, Goldman D, Erdos J, Gelernter J. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients. Am J Psychiatry (1997) 154:1451-3. doi:10.1176/ajp.154.10.1451
86. Walther DJ, Peter JU, Bashammakh S, Hörtnagl H, Voits M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science (2003) 299:76. doi:10.1126/science.1078197
87. Lopez VA, Detera-Wadleigh S, Cardona I, Kassem L, McMahon FJ, National Institute of Mental Health Genetics Initiative Bipolar Disorder Consortium. Nested association between genetic variation in tryptophan hydroxylase II, Bipolar affective disorder, and suicide attempts. Biol Psychiatry (2007) 61:181-6. doi:10.1016/j.biopsych.2006.03.028
88. Perroud N, Uher R, Ng MY, Guipponi M, Hauser J, Henigsberg N, et al. Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. Pharmacogenomics J (2012) 12:68-77. doi:10.1038/tpj.2010.70
89. Menke A, Domschke K, Czamara D, Klengel T, Hennings J, Lucae S, et al. Genome-wide association study of antidepressant treatment-emergent suicidal ideation. Neuropsychopharmacology (2012) 37:797-807. doi:10.1038/npp.2011.257
90. Laje G, Allen AS, Akula N, Manji H, John Rush A, McMahon FJ. Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients. Pharmacogenet Genomics (2009) 19:666-74. doi:10.1097/FPC.0b013e32832e4bcd
91. Van Heeringen K. Chapter 6. Stress-diathesis model of suicidal behavior. In: Dwivedi Y, editor. The Neurobiological Basis of Suicide. Boca Raton, FL: CRC Press (2012). p. 113-25.
92. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci (2003) 23(25):8788-99.
93. Serretti A, Drago A, De Ronchi D. HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Curr Med Chem (2007) 14:2053-69. doi:10.2174/092986707781368450
94. Mann JJ, Currier D. A review of prospective studies of biologic predictors of suicidal behavior in mood disorders. Arch Suicide Res (2007) 11:3-16. doi:10.1080/13811110600993124
95. Fiori LM, Wanner B, Jomphe V, Croteau J, Vitaro F, Tremblay RE, et al. Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide. PLoS One (2010) 5:e15146. doi:10.1371/journal.pone.0015146
96. Ott J. Statistical properties of the haplotype relative risk. Genet Epidemiol (1989) 6:127-30. doi:10.1002/gepi.1370060124
97. Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet (1996) 59:983-9.
98. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 66:2621-4. doi:10.1046/j.1471-4159.1996.66062621.x
99. Suda A, Kawanishi C, Kishida I, Sato R, Yamada T, Nakagawa M, et al. Dopamine D2 receptor gene polymorphisms are associated with suicide attempt in the Japanese population. Neuropsychobiology (2009) 59:130-4. doi:10.1159/000213566
100. Johann M, Putzhammer A, Eichhammer P, Wodarz N. Association of the-141C del variant of the dopamine D2 receptor (DRD2) with positive family history and suicidality in German alcoholics. Am J Med Genet B Neuropsychiatr Genet (2005) 132B:46-9. doi:10.1002/ajmg.b.30085
101. Magno LA, Miranda DM, Neves FS, Pimenta GJ, Mello MP, De Marco LA, et al. Association between AKT1 but not AKTIP genetic variants and increased risk for suicidal behavior in bipolar patients. Genes Brain Behav (2010) 9:411-8. doi:10.1111/j.1601-183X.2010.00571.x
102. De Paermentier F, Mauger JM, Lowther S, Crompton MR, Katona CL, Horton RW. Brain alpha-adrenoceptors in depressed suicides. Brain Res (1997) 757:60-8. doi:10.1016/S0006-8993(97)00138-8
103. Sequeira A, Mamdani F, Lalovic A, Anguelova M, Lesage A, Seguin M, et al. Alpha 2A adrenergic receptor gene and suicide. Psychiatry Res (2004) 125:87-93. doi:10.1016/j.psychres.2003.12.002
104. Martín-Guerrero I, Callado LF, Saitua K, Rivero G, García-Orad A, Meana JJ. The N251K functional polymorphism in the alpha(2A)-adrenoceptor gene is not associated with depression: a study in suicide completers. Psychopharmacology (Berl) (2006) 184:82-6. doi:10.1007/s00213-005-0266-2
105. Fukutake M, Hishimoto A, Nishiguchi N, Nushida H, Ueno Y, Shirakawa O, et al. Association of alpha2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females. Prog Neuropsychopharmacol Biol Psychiatry (2008) 32:1428-33. doi:10.1016/j.pnpbp.2008.02.003
106. Currier D, Mann JJ. Stress, genes and the biology of suicidal behavior. Psychiatr Clin North Am (2008) 31:247-69. doi:10.1016/j.psc.2008.01.005
107. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet (2004) 75:807-21. doi:10.1086/425589
108. Ono H, Shirakawa O, Nushida H, Ueno Y, Maeda K. Association between catechol-O-methyltransferase functional polymorphism and male suicide completers. Neuropsychopharmacology (2004) 29:1374-7. doi:10.1038/sj.npp.1300470
109. Pivac N, Pregelj P, Nikolac M, Zupanc T, Nedic G, Muck Seler D, et al. The association between catechol-O-methyl-transferase Val108/158Met polymorphism and suicide. Genes Brain Behav (2011) 10:565-9. doi:10.1111/j.1601-183X.2011.00695.x
110. De Luca V, Strauss J, Kennedy JL. Power based association analysis (PBAT) of serotonergic and noradrenergic polymorphisms in bipolar patients with suicidal behaviour. Prog Neuropsychopharmacol Biol Psychiatry (2008) 32:197-203. doi:10.1016/j.pnpbp.2007.08.008
111. Tovilla-Zárate C, Juárez-Rojop I, Ramón-Frias T, Villar-Soto M, Pool-García S, Medellín BC, et al. No association between COMT val158met polymorphism and suicidal behavior: meta-analysis and new data. BMC Psychiatry (2011) 11:151. doi:10.1186/1471-244X-11-151
112. Calati R, Porcelli S, Giegling I, Hartmann AM, Möller HJ, De Ronchi D, et al. Catechol-O-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study. J Psychiatr Res (2011) 45:309-21. doi:10.1016/j.jpsychires.2010.07.004
113. Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet (1998) 103:273-9. doi:10.1007/s004390050816
114. Lung FW, Tzeng DS, Huang MF, Lee MB. Association of the MAOA promoter uVNTR polymorphism with suicide attempts in patients with major depressive disorder. BMC Med Genet (2011) 12:74. doi:10.1186/1471-2350-12-74
115. Courtet P, Jollant F, Buresi C, Castelnau D, Mouthon D, Malafosse A. The monoamine oxidase A gene may influence the means used in suicide attempts. Psychiatr Genet (2005) 15:189-93. doi:10.1097/00041444-200509000-00009
116. Huang YY, Cate SP, Battistuzzi C, Oquendo MA, Brent D, Mann JJ. An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology (2004) 29:1498-505. doi:10.1038/sj.npp.1300455
117. Hung CF, Lung FW, Hung TH, Chong MY, Wu CK, Wen JK, et al. Monoamine oxidase A gene polymorphism and suicide: an association study and meta-analysis. J Affect Disord (2012) 136:643-9. doi:10.1016/j.jad.2011.10.013
118. Wasserman D, Sokolowski M, Rozanov V, Wasserman J. The CRHR1 gene: a marker for suicidality in depressed males exposed to low stress. Genes Brain Behav (2008) 7:14-9. doi:10.1111/j.1601-183X.2007.00310.x
119. De Luca V, Tharmalingam S, Zai C, Potapova N, Strauss J, Vincent J, et al. Association of HPA axis genes with suicidal behaviour in schizophrenia. J Psychopharmacol (2010) 24:677-82. doi:10.1177/0269881108097817
120. Ben-Efraim YJ, Wasserman D, Wasserman J, Sokolowski M. Family-based study of AVPR1B association and interaction with stressful life events on depression and anxiety in suicide attempts. Neuropsychopharmacology (2013) 38(8):1504-11. doi:10.1038/npp.2013.49
121. Banerjee R, Ghosh AK, Ghosh B, Bhattacharyya S, Mondal AC. Decreased mRNA and protein expression of BDNF, NGF, and their receptors in the hippocampus from suicide: an analysis in human postmortem brain. Clin Med Insights Pathol (2013) 6:1-11. doi:10.4137/CMPath.S12530
122. Huang TL, Lee CT. Associations between brain-derived neurotrophic factor G196A gene polymorphism and clinical phenotypes in schizophrenia patients. Chang Gung Med J (2007) 30:408-13.
123. Kim B, Kim CY, Hong JP, Kim SY, Lee C, Joo YH. Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the Met allele with suicidal behavior of bipolar patients. Neuropsychobiology (2008) 58:97-103. doi:10.1159/000162356
124. Vincze I, Perroud N, Buresi C, Baud P, Bellivier F, Etain B, et al. Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene. Bipolar Disord (2008) 10:580-7. doi:10.1111/j.1399-5618.2008.00603.x
125. Iga J, Ueno S, Yamauchi K, Numata S, Tayoshi-Shibuya S, Kinouchi S, et al. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients. Am J Med Genet B Neuropsychiatr Genet (2007) 144B:1003-6. doi:10.1002/ajmg.b.30520
126. Sarchiapone M, Carli V, Roy A, Iacoviello L, Cuomo C, Latella MC, et al. Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients. Neuropsychobiology (2008) 57:139-45. doi:10.1159/000142361
127. Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology (2003) 48:186-9. doi:10.1159/000074636
128. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging (2006) 27:1834-7. doi:10.1016/j.neurobiolaging.2005.10.013
129. Perroud N, Courtet P, Vincze I, Jaussent I, Jollant F, Bellivier F, et al. Interaction between BDNF Val66Met and childhood trauma on adult's violent suicide attempt. Genes Brain Behav (2008) 7:314-22. doi:10.1111/j.1601-183X.2007.00354.x
130. Sears C, Wilson J, Fitches A. Investigating the role of BDNF and CCK system genes in suicidality in a familial bipolar cohort. J Affect Disord (2013) 151(2):611-7. doi:10.1016/j.jad.2013.07.006
131. Zarrilli F, Angiolillo A, Castaldo G, Chiariotti L, Keller S, Sacchetti S, et al. Brain derived neurotrophic factor (BDNF) genetic polymorphism (Val66Met) in suicide: a study of 512 cases. Am J Med Genet B Neuropsychiatr Genet (2009) 150B:599-600. doi:10.1002/ajmg.b.30849
132. Kohli MA, Salyakina D, Pfennig A, Lucae S, Horstmann S, Menke A, et al. Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients. Arch Gen Psychiatry (2010) 67:348-59. doi:10.1001/archgenpsychiatry.2009.201
133. Pregelj P, Nedic G, Paska AV, Zupanc T, Nikolac M, Balažic J, et al. The association between brain-derived neurotrophic factor polymorphism (BDNF Val66Met) and suicide. J Affect Disord (2011) 128:287-90. doi:10.1016/j.jad.2010.07.001
134. Strauss J, McGregor S, Freeman N, Tiwari A, George CJ, Kovacs M, et al. Association study of early-immediate genes in childhood-onset mood disorders and suicide attempt. Psychiatry Res (2012) 197(1-2):49-54. doi:10.1016/j.psychres.2011.11.022
135. Ropret S, Zupanc T, Komel R, Videtic Paska A. Single nucleotide polymorphisms in the BDNF gene and suicide in the Slovenian sample. Neurosci Lett (2015) 602:12-6. doi:10.1016/j.neulet.2015.06.027
136. Ratta-Apha W, Hishimoto A, Yoshida M, Ueno Y, Asano M, Shirakawa O, et al. Association study of BDNF with completed suicide in the Japanese population. Psychiatry Res (2013) 209:734-6. doi:10.1016/j.psychres.2013.05.030
137. Zai CC, Manchia M, De Luca V, Tiwari AK, Chowdhury NI, Zai GC, et al. The brain-derived neurotrophic factor gene in suicidal behaviour: a meta-analysis. Int J Neuropsychopharmacol (2012) 15(8):1037-42. doi:10.1017/S1461145711001313
138. Sokolowski M, Ben-Efraim YJ, Wasserman J, Wasserman D. Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: associations and gene-environment interactions with childhood/adolescent physical assault. Mol Psychiatry (2013) 18(9):985-92. doi:10.1038/mp.2012.112
139. Laje G, Paddock S, Manji H, Rush AJ, Wilson AF, Charney D, et al. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry (2007) 164:1530-8. doi:10.1176/appi.ajp.2007.06122018
140. Wasserman D, Geijer T, Rozanov V, Wasserman J. Suicide attempt and basic mechanisms in neural conduction: relationships to the SCN8A and VAMP4 genes. Am J Med Genet B Neuropsychiatr Genet (2005) 133B(1):116-9. doi:10.1002/ajmg.b.30128
141. Rowe SJ, Tenesa A. Human complex trait genetics: lifting the lid of the genomics toolbox-from pathways to prediction. Curr Genomics (2012) 13:213-24. doi:10.2174/138920212800543101
142. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet (2006) 38:904-9. doi:10.1038/ng1847
143. Li MX, Yeung JM, Cherny SS, Sham PC. Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets. Hum Genet (2012) 131:747-56. doi:10.1007/s00439-011-1118-2
144. Perlis RH, Huang J, Purcell S, Fava M, Rush AJ, Sullivan PF, et al. Genome-wide association study of suicide attempts in mood disorder patients. Am J Psychiatry (2010) 167:1499-507. doi:10.1176/appi.ajp.2010.10040541
145. Willour VL, Seifuddin F, Mahon PB, Jancic D, Pirooznia M, Steele J, et al. A genome-wide association study of attempted suicide. Mol Psychiatry (2012) 17:433-44. doi:10.1038/mp.2011.4
146. Schosser A, Butler AW, Ising M, Perroud N, Uher R, Ng MY, et al. Genomewide association scan of suicidal thoughts and behaviour in major depression. PLoS One (2011) 6:e20690. doi:10.1371/journal.pone.0020690
147. Galfalvy H, Zalsman G, Huang YY, Murphy L, Rosoklija G, Dwork AJ, et al. A pilot genome wide association and gene expression array study of suicide with and without major depression. World J Biol Psychiatry (2013) 14:574-82. doi:10.3109/15622975.2011.597875
148. Mullins N, Perroud N, Uher R, Butler AW, Cohen-Woods S, Rivera M, et al. Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study. Am J Med Genet B Neuropsychiatr Genet (2014) 165B:428-37. doi:10.1002/ajmg.b.32247
149. Galfalvy H, Haghighi F, Hodgkinson C, Goldman D, Oquendo MA, Burke A, et al. A genome-wide association study of suicidal behavior. Am J Med Genet B Neuropsychiatr Genet (2015) 168:557-63. doi:10.1002/ajmg.b.32330
150. Zai CC, Gonçalves VF, Tiwari AK, Gagliano SA, Hosang G, de Luca V, et al. A genome-wide association study of suicide severity scores in bipolar disorder. J Psychiatr Res (2015) 65:23-9. doi:10.1016/j.jpsychires.2014.11.002
151. Sokolowski M, Wasserman J, Wasserman D. Polygenic associations of neurodevelopmental genes in suicide attempt. Mol Psychiatry (2015) 1-10. doi:10.1038/mp.2015.187
152. Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics (2003) 19:149-50. doi:10.1016/j.eurpsy.2006.12.001
153. Palmer LJ, Cardon LR. Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet (2005) 366:1223-34. doi:10.1016/S0140-6736(05)67485-5
154. Wray NR, Goddard ME, Visscher PM. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res (2007) 17:1520-8. doi:10.1101/gr.6665407
155. Lasky-Su J, Lange C. Statistical challenges for genome-wide association studies of suicidality using family data. Eur Psychiatry (2010) 25:307-9. doi:10.1016/j.eurpsy.2009.12.019
156. Dudbridge F. Power and predictive accuracy of polygenic risk scores. PLoS Genet (2013) 9:e1003348. doi:10.1371/journal.pgen.1003348
157. Cross-Disorder Group of the Psychiatric Genomics Consortium. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 45(9):984-94. doi:10.1038/ng.2711
158. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci (1999) 2:861-3. doi:10.1038/13158
159. Cordell HJ. Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet (2009) 10:392-404. doi:10.1038/nrg2579
160. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet (2012) 13:537-51. doi:10.1038/nrg3240
161. Gross JA, Bureau A, Croteau J, Galfalvy H, Oquendo MA, Haghighi F, et al. A genome-wide copy number variant study of suicidal behavior. PLoS One (2015) 10(5):e0128369. doi:10.1371/journal.pone.0128369
162. Perlis RH, Ruderfer D, Hamilton SP, Ernst C. Copy number variation in subjects with major depressive disorder who attempted suicide. PLoS One (2012) 7:e46315. doi:10.1371/journal.pone.0046315
163. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet (2010) 11:446-50. doi:10.1038/nrg2809
164. Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci (2007) 8(5):355-67. doi:10.1038/nrn2132
165. Turecki G, Ota VK, Belangero SI, Jackowski A, Kaufman J. Early life adversity, genomic plasticity, and psychopathology. Lancet Psychiatry (2014) 1(6):461-6. doi:10.1016/S2215-0366(14)00022-4
166. McGowan PO, Sasaki A, Huang TC, Unterberger A, Suderman M, Ernst C, et al. Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS One (2008) 3(5):e2085. doi:10.1371/journal.pone.0002085
167. Ernst C, Chen ES, Turecki G. Histone methylation and decreased expression of TrkB.T1 in orbital frontal cortex of suicide completers. Mol Psychiatry (2009) 14:830-2. doi:10.1038/mp.2009.35
168. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonté B, Szyf M, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci (2009) 12:342-8. doi:10.1038/nn.2270
169. Fiori LM, Turecki G. Genetic and epigenetic influences on expression of spermine synthase and spermine oxidase in suicide completers. Int J Neuropsychopharmacol (2010) 13(6):725-36. doi:10.1017/S1461145709991167
170. Keller S, Sarchiapone M, Zarrilli F, Videtic A, Ferraro A, Carli V, et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry (2010) 67(3):258-67. doi:10.1001/archgenpsychiatry.2010.9
171. Kaminsky Z, Wilcox HC, Eaton WW, Van Eck K, Kilaru V, Jovanovic T, et al. Epigenetic and genetic variation at SKA2 predict suicidal behavior and post-traumatic stress disorder. Transl Psychiatry (2015) 5:e627. doi:10.1038/tp.2015.105